Completed
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
NCT03013543
- Conditions
- Abnormalities, Multiple, Body Weight, Chromosome Disorders, +15 more
- Locations
-
- Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC Birmingham, Alabama, United States
- Synexus Clinical Research US, Inc. - Phoenix Southeast Chandler, Arizona, United States
- Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC Mesa, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States